
The closing price for Regeneron Pharmaceuticals (REGN) between July 1, 2012 and October 1, 2012 was $152.98, on October 1, 2012. It was up 34.1% in that time. The latest price is $750.43.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
October 01 2012 | $151.68 | $154.26 | $150.85 | $152.98 | 959,900 |
September 28 2012 | $149.25 | $151.96 | $148.42 | $151.23 | 827,100 |
September 27 2012 | $141.89 | $150.46 | $141.86 | $149.79 | 996,500 |
September 26 2012 | $144.23 | $144.93 | $140.84 | $141.63 | 786,600 |
September 25 2012 | $143.44 | $147.23 | $143.44 | $144.64 | 717,700 |
September 24 2012 | $143.89 | $144.38 | $140.80 | $142.81 | 644,500 |
September 21 2012 | $144.09 | $145.80 | $143.55 | $143.73 | 1,385,400 |
September 20 2012 | $144.58 | $146.35 | $143.99 | $144.85 | 462,000 |
September 19 2012 | $145.56 | $146.86 | $144.07 | $144.55 | 627,200 |
September 18 2012 | $147.71 | $149.27 | $145.50 | $145.70 | 478,400 |
September 17 2012 | $147.68 | $150.41 | $147.61 | $148.31 | 716,900 |
September 14 2012 | $146.44 | $150.06 | $146.34 | $148.28 | 584,000 |
September 13 2012 | $144.94 | $146.56 | $144.41 | $145.52 | 579,200 |
September 12 2012 | $147.61 | $147.91 | $140.51 | $144.27 | 987,700 |
September 11 2012 | $148.09 | $148.76 | $146.84 | $147.37 | 363,100 |
September 10 2012 | $150.23 | $150.50 | $148.65 | $148.89 | 460,500 |
September 07 2012 | $151.17 | $151.50 | $149.89 | $151.12 | 781,000 |
September 06 2012 | $148.60 | $152.54 | $148.19 | $151.02 | 698,600 |
September 05 2012 | $148.16 | $148.60 | $146.23 | $148.06 | 686,200 |
September 04 2012 | $147.01 | $149.41 | $145.04 | $148.76 | 693,900 |
August 31 2012 | $144.44 | $146.84 | $142.62 | $146.67 | 690,500 |
August 30 2012 | $143.18 | $144.98 | $141.08 | $144.15 | 695,300 |
August 29 2012 | $145.57 | $145.63 | $143.24 | $144.12 | 413,800 |
August 28 2012 | $144.18 | $146.02 | $142.65 | $145.40 | 659,800 |
August 27 2012 | $143.03 | $145.00 | $142.00 | $144.13 | 526,800 |
Daily pricing data for Regeneron Pharmaceuticals dates back to 4/2/1991, and may be incomplete.